Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipocytes | 9 | 2017 | 1180 | 1.110 |
Why?
|
| Stromal Cells | 7 | 2017 | 1353 | 0.970 |
Why?
|
| Mammaplasty | 6 | 2020 | 1202 | 0.880 |
Why?
|
| Tissue Expansion Devices | 1 | 2020 | 156 | 0.700 |
Why?
|
| Capacity Building | 1 | 2022 | 248 | 0.690 |
Why?
|
| Esophagoplasty | 1 | 2018 | 43 | 0.630 |
Why?
|
| Free Tissue Flaps | 4 | 2017 | 328 | 0.610 |
Why?
|
| Adipogenesis | 4 | 2017 | 356 | 0.600 |
Why?
|
| Tissue Transplantation | 1 | 2017 | 130 | 0.570 |
Why?
|
| Adipose Tissue | 7 | 2017 | 3285 | 0.520 |
Why?
|
| Omentum | 1 | 2015 | 170 | 0.480 |
Why?
|
| Esophagectomy | 1 | 2018 | 448 | 0.480 |
Why?
|
| Catheters | 1 | 2017 | 432 | 0.480 |
Why?
|
| Stomach | 1 | 2018 | 695 | 0.460 |
Why?
|
| Thoracic Wall | 1 | 2015 | 202 | 0.450 |
Why?
|
| Thoracic Neoplasms | 1 | 2015 | 268 | 0.440 |
Why?
|
| Mastectomy | 3 | 2020 | 1794 | 0.430 |
Why?
|
| Graft Survival | 3 | 2017 | 3717 | 0.420 |
Why?
|
| Lipectomy | 4 | 2017 | 118 | 0.400 |
Why?
|
| Surgical Flaps | 2 | 2018 | 1646 | 0.360 |
Why?
|
| Colon | 1 | 2018 | 1776 | 0.350 |
Why?
|
| Surgical Procedures, Operative | 1 | 2021 | 1874 | 0.330 |
Why?
|
| Fibrosis | 1 | 2016 | 2007 | 0.330 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 1999 | 0.300 |
Why?
|
| Patient Participation | 1 | 2016 | 1454 | 0.280 |
Why?
|
| Decision Support Techniques | 2 | 2016 | 1964 | 0.280 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 1438 | 0.260 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 3397 | 0.230 |
Why?
|
| Trigger Finger Disorder | 1 | 2023 | 52 | 0.210 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2023 | 124 | 0.190 |
Why?
|
| Vietnam | 1 | 2022 | 408 | 0.190 |
Why?
|
| Microsurgery | 2 | 2017 | 797 | 0.190 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9407 | 0.170 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2023 | 300 | 0.170 |
Why?
|
| Surgery, Plastic | 2 | 2015 | 625 | 0.160 |
Why?
|
| Breast Implants | 1 | 2020 | 387 | 0.140 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2017 | 1630 | 0.140 |
Why?
|
| Osteogenesis | 4 | 2017 | 1294 | 0.140 |
Why?
|
| Fractures, Open | 1 | 2017 | 101 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 20723 | 0.140 |
Why?
|
| Abdominal Muscles | 1 | 2017 | 166 | 0.140 |
Why?
|
| Buttocks | 1 | 2016 | 110 | 0.130 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2016 | 96 | 0.130 |
Why?
|
| X-Ray Microtomography | 1 | 2017 | 428 | 0.130 |
Why?
|
| Transplantation, Autologous | 2 | 2017 | 2122 | 0.130 |
Why?
|
| Magnetite Nanoparticles | 1 | 2016 | 319 | 0.120 |
Why?
|
| Tibial Fractures | 1 | 2017 | 269 | 0.120 |
Why?
|
| Thigh | 1 | 2015 | 246 | 0.120 |
Why?
|
| Abdominal Fat | 1 | 2015 | 223 | 0.120 |
Why?
|
| Data Collection | 2 | 2021 | 3344 | 0.110 |
Why?
|
| Bone Regeneration | 1 | 2016 | 427 | 0.110 |
Why?
|
| Program Evaluation | 1 | 2022 | 2481 | 0.110 |
Why?
|
| Wound Healing | 4 | 2017 | 2777 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2015 | 392 | 0.100 |
Why?
|
| Microvessels | 1 | 2016 | 542 | 0.100 |
Why?
|
| Equipment Design | 2 | 2017 | 3574 | 0.100 |
Why?
|
| Reoperation | 1 | 2020 | 4210 | 0.090 |
Why?
|
| Humans | 27 | 2023 | 743521 | 0.090 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2013 | 330 | 0.090 |
Why?
|
| Regeneration | 2 | 2017 | 1485 | 0.090 |
Why?
|
| Hemorheology | 1 | 2011 | 145 | 0.090 |
Why?
|
| Flow Cytometry | 3 | 2017 | 5970 | 0.090 |
Why?
|
| Cleft Lip | 1 | 2015 | 479 | 0.090 |
Why?
|
| Postoperative Complications | 4 | 2023 | 15280 | 0.090 |
Why?
|
| Nerve Block | 1 | 2017 | 639 | 0.090 |
Why?
|
| Patient Transfer | 1 | 2017 | 762 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2022 | 77457 | 0.090 |
Why?
|
| Cost Sharing | 1 | 2013 | 408 | 0.090 |
Why?
|
| Developing Countries | 1 | 2022 | 2817 | 0.090 |
Why?
|
| Drug Design | 1 | 2015 | 1077 | 0.090 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2013 | 547 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1430 | 0.090 |
Why?
|
| Career Choice | 1 | 2015 | 742 | 0.080 |
Why?
|
| Synovial Fluid | 1 | 2011 | 396 | 0.080 |
Why?
|
| Radiotherapy | 1 | 2016 | 1529 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2022 | 3203 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 39047 | 0.080 |
Why?
|
| Blood | 1 | 2011 | 594 | 0.080 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 2054 | 0.080 |
Why?
|
| Mice | 8 | 2017 | 80999 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2017 | 5976 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 3603 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2016 | 4209 | 0.070 |
Why?
|
| Appendicitis | 1 | 2013 | 646 | 0.070 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 1640 | 0.070 |
Why?
|
| Middle Aged | 11 | 2020 | 213185 | 0.070 |
Why?
|
| Education, Medical, Graduate | 2 | 2015 | 2289 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 3622 | 0.070 |
Why?
|
| Adult | 12 | 2017 | 213870 | 0.060 |
Why?
|
| Critical Care | 1 | 2018 | 2646 | 0.060 |
Why?
|
| Animals | 12 | 2017 | 168434 | 0.060 |
Why?
|
| Internship and Residency | 2 | 2015 | 5787 | 0.060 |
Why?
|
| Blood Coagulation | 1 | 2011 | 1136 | 0.060 |
Why?
|
| Length of Stay | 1 | 2018 | 6295 | 0.060 |
Why?
|
| Arthroscopy | 1 | 2010 | 925 | 0.060 |
Why?
|
| Female | 15 | 2020 | 379875 | 0.060 |
Why?
|
| Cartilage, Articular | 1 | 2010 | 1095 | 0.060 |
Why?
|
| Stem Cells | 1 | 2016 | 3566 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 2404 | 0.050 |
Why?
|
| Skin | 1 | 2016 | 4368 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2013 | 1904 | 0.050 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2013 | 2032 | 0.050 |
Why?
|
| Cell Survival | 3 | 2016 | 5865 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 3842 | 0.050 |
Why?
|
| Arthroplasty | 1 | 2023 | 306 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2017 | 3658 | 0.040 |
Why?
|
| Cell Differentiation | 4 | 2017 | 11464 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 2 | 2016 | 1351 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 17981 | 0.040 |
Why?
|
| United States | 3 | 2022 | 69834 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2016 | 2503 | 0.030 |
Why?
|
| Suction | 1 | 2016 | 267 | 0.030 |
Why?
|
| Cattle | 2 | 2011 | 3924 | 0.030 |
Why?
|
| Amides | 1 | 2017 | 459 | 0.030 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 3667 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2015 | 689 | 0.030 |
Why?
|
| Lentivirus | 1 | 2016 | 503 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 905 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 1855 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2016 | 53285 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2013 | 548 | 0.020 |
Why?
|
| Male | 7 | 2017 | 349771 | 0.020 |
Why?
|
| Breast | 1 | 2020 | 1947 | 0.020 |
Why?
|
| Arteries | 1 | 2016 | 1114 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2013 | 573 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2013 | 732 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2015 | 803 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 20130 | 0.020 |
Why?
|
| Mentors | 1 | 2015 | 630 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2015 | 1163 | 0.020 |
Why?
|
| Anesthetics, Local | 1 | 2017 | 982 | 0.020 |
Why?
|
| Financing, Government | 1 | 2013 | 465 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2016 | 958 | 0.020 |
Why?
|
| Models, Economic | 1 | 2013 | 711 | 0.020 |
Why?
|
| Biomedical Engineering | 1 | 2010 | 294 | 0.020 |
Why?
|
| Cicatrix | 1 | 2015 | 763 | 0.020 |
Why?
|
| Cartilage Diseases | 1 | 2010 | 160 | 0.020 |
Why?
|
| Permeability | 1 | 2011 | 736 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1671 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2013 | 1681 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 1675 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2017 | 3419 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 4015 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 35300 | 0.020 |
Why?
|
| Ischemia | 1 | 2015 | 1905 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2013 | 1703 | 0.020 |
Why?
|
| Motivation | 1 | 2015 | 1967 | 0.020 |
Why?
|
| Hydrogels | 1 | 2010 | 725 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2015 | 4025 | 0.020 |
Why?
|
| Income | 1 | 2013 | 1913 | 0.020 |
Why?
|
| Burns | 1 | 2015 | 1815 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2711 | 0.010 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2013 | 1209 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8364 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2013 | 2122 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 5370 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2017 | 63105 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2015 | 4678 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 19213 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7901 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 12024 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7271 | 0.010 |
Why?
|
| Phenotype | 1 | 2015 | 16338 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 25058 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 163137 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 29209 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 72325 | 0.010 |
Why?
|
| Neoplasms | 1 | 2015 | 21670 | 0.000 |
Why?
|
Concepts
(168)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_